Lysine receptor on plasminogen — Drug Target
All drugs that target Lysine receptor on plasminogen — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- tranexamic acid (Exacyl®) · Institut Kassab d'Orthopédie · Antifibrinolytic · Oncology, Surgery
Tranexamic acid works by inhibiting the activation of plasminogen to plasmin, thereby preventing the breakdown of fibrin clots.